These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7510085)

  • 21. Identification of a cytotoxic T-cell epitope on the recombinant nucleocapsid proteins of Rinderpest and Peste des petits ruminants viruses presented as assembled nucleocapsids.
    Mitra-Kaushik S; Nayak R; Shaila MS
    Virology; 2001 Jan; 279(1):210-20. PubMed ID: 11145903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
    Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
    J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTL escape viral variants. II. Biologic activity in vivo.
    Lewicki HA; Von Herrath MG; Evans CF; Whitton JL; Oldstone MB
    Virology; 1995 Aug; 211(2):443-50. PubMed ID: 7645248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity.
    Boon AC; de Mutsert G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2006 Jun; 80(12):6024-32. PubMed ID: 16731941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes.
    Beauverger P; Buckland R; Wild F
    Virology; 1994 Apr; 200(1):281-3. PubMed ID: 7510439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
    Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
    J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
    Gorman WL; Gill DS; Scroggs RA; Portner A
    Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary in vitro sensitization of virus specific cytotoxic T lymphocytes.
    Jung H; Pfizenmaier K; Starzinski-Powitz A; Röllinghoff M; Wagner H
    Immunology; 1978 Apr; 34(4):763-9. PubMed ID: 82534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles virus antigens induce both type-specific and canine distemper virus cross-reactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope.
    Beauverger P; Buckland R; Wild TF
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2357-63. PubMed ID: 7504072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination.
    Kast WM; Brandt RM; Melief CJ
    Eur J Immunol; 1993 May; 23(5):1189-92. PubMed ID: 8386667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
    Jones B; Zhan X; Mishin V; Slobod KS; Surman S; Russell CJ; Portner A; Hurwitz JL
    Vaccine; 2009 Mar; 27(12):1848-57. PubMed ID: 19200447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elicitation of primary anti-Sendai virus cytotoxic T lymphocytes with purified viral glycoproteins.
    McGee M; Hale AH; Panetti M
    Eur J Immunol; 1980 Dec; 10(12):923-8. PubMed ID: 6258925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral antigens act as helper determinants for antibody responses to cell surface antigens.
    Bromberg JS; Lake P; Brunswick M
    J Immunol; 1982 Aug; 129(2):683-8. PubMed ID: 6177775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elicitation of anti-viral cytotoxic T lymphocytes with purified viral and H-2 antigens.
    Hale AH; Ruebush MJ; Harris DT
    J Immunol; 1980 Jul; 125(1):428-30. PubMed ID: 6247399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.
    de Waal LP; Kast WM; Melvold RW; Melief CJ
    J Immunol; 1983 Mar; 130(3):1090-6. PubMed ID: 6185570
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
    Kast WM; Roux L; Curren J; Blom HJ; Voordouw AC; Meloen RH; Kolakofsky D; Melief CJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2283-7. PubMed ID: 1848698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.
    Melief CJ; Stukart MJ; de Waal LP; Kast WM; Melvold RW
    Transplant Proc; 1983 Dec; 15(4):2086-9. PubMed ID: 6324427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.